HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neonatal presentation of ventricular tachycardia and a Reye-like syndrome episode associated with disturbed mitochondrial energy metabolism.

AbstractBACKGROUND:
Hyperammonemia, hypoglycemia, hepatopathy, and ventricular tachycardia are common presenting features of carnitine-acylcarnitine translocase deficiency (Mendelian Inheritance in Man database: *212138), a mitochondrial fatty acid oxidation disorder with a lethal prognosis. These features have not been identified as the presenting features of mitochondrial cytopathy in the neonatal period.
CASE PRESENTATION:
We describe an atypical presentation of mitochondrial cytopathy in a 2 day-old neonate. She presented with a Reye-like syndrome episode, premature ventricular contractions and ventricular tachycardia. Initial laboratory evaluation exhibited a large amount of 3-methylglutaconic acid on urine organic acid analysis, mild orotic aciduria and a nonspecific abnormal acylcarnitine profile. The evaluation for carnitine-acylcarnitine translocase deficiency and other fatty acid oxidation disorders was negative. The patient later developed a hypertrophic cardiomyopathy and continued to be affected by recurrent Reye-like syndrome episodes triggered by infections. A muscle biopsy exhibited signs of a mitochondrial cytopathy. During the course of her disease, her Reye-like syndrome episodes have subsided; however, cardiomyopathy has persisted along with fatigue and exercise intolerance.
CONCLUSIONS:
This case illustrates that, in the neonatal period, hyperammonemia and ventricular tachycardia may be the presenting features of a lethal carnitine-acylcarnitine translocase deficiency or of a mitochondrial cytopathy, associated with a milder clinical course. This association broadens the spectrum of presenting phenotypes observed in patients with disturbed mitochondrial energy metabolism. Also, the presence of 3-methylglutaconic aciduria suggests mitochondrial dysfunction and mild orotic aciduria could potentially be used as a marker of mitochondrial disease.
AuthorsFernando Scaglia, Angela E Scheuerle, Jeffrey A Towbin, Dawna L Armstrong, Lawrence Sweetman, Lee-Jun C Wong
JournalBMC pediatrics (BMC Pediatr) Vol. 2 Pg. 12 (Dec 30 2002) ISSN: 1471-2431 [Electronic] England
PMID12507404 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Biomarkers
  • DNA, Mitochondrial
  • Glutarates
  • acylcarnitine
  • 3-methylglutaconic acid
  • Orotic Acid
  • Carnitine
Topics
  • Biomarkers (urine)
  • Carnitine (analogs & derivatives, analysis)
  • DNA, Mitochondrial (genetics)
  • Female
  • Glutarates (urine)
  • Humans
  • Infant, Newborn
  • Mitochondrial Myopathies (complications, diagnosis, metabolism)
  • Mutation
  • Orotic Acid (urine)
  • Reye Syndrome (complications, diagnosis, metabolism)
  • Tachycardia, Ventricular (complications, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: